News & Updates

A prospective, randomized, multicentre pilot study finds that early addition of cerebrolysin to reperfusion therapy is safe and significantly reduces the rate of haemorrhagic transformation (HT) after acute ischaemic stroke (AIS).

People who receive an mRNA SARS-CoV-2 vaccine do not appear to be at increased risk of stroke within the first 28 days of immunization, as shown in a large study.

Initial frailty status appears to be a potential predictor of the occurrence of the composite of probable dementia and mild cognitive impairment, and this association is strengthened by intensive blood pressure control, as reported in a study.

Anticoagulation therapy with apixaban yields lower rates of ischaemic stroke and intracranial and extracranial major bleeding compared with other oral anticoagulants (OACs) in patients with atrial fibrillation (AF), with the magnitude of benefit for major bleeding even greater for those who have dementia, according to a study.

For people undergoing chemotherapy, tuning in to some music may help soothe nausea symptoms, as reported in a small pilot study.